首页> 美国卫生研究院文献>other >LigSeeSVM: Ligand-Based Virtual Screening Using Support Vector Machines and Information Fusion
【2h】

LigSeeSVM: Ligand-Based Virtual Screening Using Support Vector Machines and Information Fusion

机译:LigseesVm:配体为基础的虚拟筛选支持向量机和信息融合

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Structure-based virtual screening of molecular compound libraries is a potentially powerful and inexpensive method for the discovery of novel lead compounds for drug development. That said, virtual screening is heavily dependent on detailed understanding of the tertiary or quaternary structure of the protein target of interest, including knowledge of the relevant binding pocket. Such information is often difficult or impossible to obtain. In contrast, ligand-based in silico drug screening can perform screening on drug targets whose three-dimensional structure is not yet determined. We previously demonstrated that the use of data fusion techniques strengthen virtual screening. Building on this data, we here describe LigSeeSVM, a ligand-based screening tool using data fusion and Support vector machines and termed. We combine atom pair (AP) structure descriptors and physicochemical (PC) descriptors to characterize compounds’ features. We used SVM to generate SVM-AP model based on 825 AP descriptors and SVM-PC model based on 19 physicochemical descriptors. We combine SVM-AP and SVM-PC using rank-based information fusion to create LigSeeSVM model. LigSeeSVM was evaluated on five data sets, including thymindine kinase (TK) substrates, estrogen receptor (ER) antagonists, estrogen receptor agonists (ERA), GPCR and GABAA ligands. Our results suggest that LigSeeSVM is useful for ligand-based virtual screening and offers competitive performance to other ligand-based screening approaches.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号